Natural history of lean and non-lean metabolic dysfunction-associated steatotic liver disease
ConclusionLean MASLD exhibits a similar LRE risk and a lower CVE risk to non-lean MASLD. Therefore, follow-up and treatment strategies should be tailored to the specific MASLD condition.
Source: Journal of Gastroenterology - Category: Gastroenterology Source Type: research
More News: Cardiology | Cardiovascular | Databases & Libraries | Gastroenterology | Heart | Liver | Liver Disease | Study | Urology & Nephrology